Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1971 4
1972 12
1973 7
1974 6
1975 3
1976 6
1977 2
1978 3
1979 2
1980 4
1981 5
1982 7
1983 6
1984 11
1985 7
1986 8
1987 11
1988 17
1989 10
1990 15
1991 16
1992 16
1993 25
1994 21
1995 28
1996 20
1997 18
1998 20
1999 27
2000 30
2001 13
2002 25
2003 27
2004 22
2005 40
2006 30
2007 30
2008 33
2009 41
2010 53
2011 40
2012 56
2013 60
2014 49
2015 59
2016 42
2017 49
2018 47
2019 49
2020 45
2021 43
2022 23
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

1,154 results

Results by year

Filters applied: . Clear all
Page 1
TGF-β Signaling in Control of Cardiovascular Function.
Goumans MJ, Ten Dijke P. Goumans MJ, et al. Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):a022210. doi: 10.1101/cshperspect.a022210. Cold Spring Harb Perspect Biol. 2018. PMID: 28348036 Free PMC article. Review.
Arrhythmogenic Cardiomyopathy.
Corrado D, Basso C, Judge DP. Corrado D, et al. Circ Res. 2017 Sep 15;121(7):784-802. doi: 10.1161/CIRCRESAHA.117.309345. Circ Res. 2017. PMID: 28912183 Review.
Pathological features include loss of myocytes and fibrofatty replacement of right ventricular myocardium; biventricular involvement is often observed. It is a cell-to-cell junction cardiomyopathy, typically caused by genetically determined abnormalities of cardiac …
Pathological features include loss of myocytes and fibrofatty replacement of right ventricular myocardium; biventricular involvement …
Regulated cell death pathways in cardiomyopathy.
Sheng SY, Li JM, Hu XY, Wang Y. Sheng SY, et al. Acta Pharmacol Sin. 2023 Aug;44(8):1521-1535. doi: 10.1038/s41401-023-01068-9. Epub 2023 Mar 13. Acta Pharmacol Sin. 2023. PMID: 36914852 Review.
Importantly, these forms of regulated cell death (RCD) are cardinal features in the pathogenesis of various cardiomyopathies, including dilated cardiomyopathy, diabetic cardiomyopathy, sepsis-induced cardiomyopathy, and drug-induced cardiomyopathy. The relevance between abnorm …
Importantly, these forms of regulated cell death (RCD) are cardinal features in the pathogenesis of various cardiomyopathies, including dila …
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G, Hill MA, Sowers JR. Jia G, et al. Circ Res. 2018 Feb 16;122(4):624-638. doi: 10.1161/CIRCRESAHA.117.311586. Circ Res. 2018. PMID: 29449364 Free PMC article. Review.
Impaired cardiac insulin metabolic signaling, mitochondrial dysfunction, increases in oxidative stress, reduced nitric oxide bioavailability, elevations in advanced glycation end products and collagen-based cardiomyocyte and extracellular matrix stiffness, impaired mitochondrial …
Impaired cardiac insulin metabolic signaling, mitochondrial dysfunction, increases in oxidative stress, reduced nitric oxide bioavailability …
Physiological and pathological roles of protein kinase A in the heart.
Liu Y, Chen J, Fontes SK, Bautista EN, Cheng Z. Liu Y, et al. Cardiovasc Res. 2022 Jan 29;118(2):386-398. doi: 10.1093/cvr/cvab008. Cardiovasc Res. 2022. PMID: 33483740 Free PMC article. Review.
Protein kinase A (PKA) is a central regulator of cardiac performance and morphology. Myocardial PKA activation is induced by a variety of hormones, neurotransmitters, and stress signals, most notably catecholamines secreted by the sympathetic nervous system. ...Dynamic con …
Protein kinase A (PKA) is a central regulator of cardiac performance and morphology. Myocardial PKA activation is induced by a variet …
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Marcus FI, et al. Eur Heart J. 2010 Apr;31(7):806-14. doi: 10.1093/eurheartj/ehq025. Epub 2010 Feb 19. Eur Heart J. 2010. PMID: 20172912 Free PMC article.
In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. ...
In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of com …
Cardiac Neural Crest.
Yamagishi H. Yamagishi H. Cold Spring Harb Perspect Biol. 2021 Jan 4;13(1):a036715. doi: 10.1101/cshperspect.a036715. Cold Spring Harb Perspect Biol. 2021. PMID: 32071091 Free PMC article. Review.
Recent studies focus more on reciprocal signaling between the CNC and cells originated from the second heart field (SHF), which are essential for the development of the OFT myocardium, providing new insights into the molecular mechanisms underlying congenital heart …
Recent studies focus more on reciprocal signaling between the CNC and cells originated from the second heart field (SHF), which are essentia …
Review: Acetylation mechanisms and targeted therapies in cardiac fibrosis.
Liu W, Yuan Q, Cao S, Wang G, Liu X, Xia Y, Bian Y, Xu F, Chen Y. Liu W, et al. Pharmacol Res. 2023 Jul;193:106815. doi: 10.1016/j.phrs.2023.106815. Epub 2023 Jun 6. Pharmacol Res. 2023. PMID: 37290541 Free article. Review.
However, to date, few effective therapies for cardiac fibrosis exist. Abnormal proliferation, differentiation, and migration of cardiac fibroblasts are responsible for the excessive deposition of extracellular matrix in the myocardium. ...
However, to date, few effective therapies for cardiac fibrosis exist. Abnormal proliferation, differentiation, and migration of cardi …
Cirrhotic cardiomyopathy.
Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, Afeltra A, Sanyal AJ. Zardi EM, et al. J Am Coll Cardiol. 2010 Aug 10;56(7):539-49. doi: 10.1016/j.jacc.2009.12.075. J Am Coll Cardiol. 2010. PMID: 20688208 Free article. Review.
Cirrhotic cardiomyopathy is a clinical syndrome in patients with liver cirrhosis characterized by an abnormal and blunted response to physiologic, pathologic, or pharmacologic stress but normal to increased cardiac output and contractility at rest. ...
Cirrhotic cardiomyopathy is a clinical syndrome in patients with liver cirrhosis characterized by an abnormal and blunted response to …
Cardiomyopathies in children: An overview.
Tsatsopoulou A, Protonotarios I, Xylouri Z, Papagiannis I, Anastasakis A, Germanakis I, Patrianakos A, Nyktari E, Gavras C, Papadopoulos G, Meditskou S, Lazarou E, Miliou A, Lazaros G. Tsatsopoulou A, et al. Hellenic J Cardiol. 2023 Jul-Aug;72:43-56. doi: 10.1016/j.hjc.2023.02.007. Epub 2023 Mar 3. Hellenic J Cardiol. 2023. PMID: 36870438 Free article. Review.
Paediatric cardiomyopathies form a heterogeneous group of disorders characterized by structural and electrical abnormalities of the heart muscle, commonly due to a gene variant of the myocardial cell structure. Mostly inherited as a dominant or occasionally recessive trait …
Paediatric cardiomyopathies form a heterogeneous group of disorders characterized by structural and electrical abnormalities of the h …
1,154 results